Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College—Rhode Island, 2015–2016 | Zendy

Heidi M. Soeters | Zendy; Melissa Whaley | Zendy; Nicole AlexanderScott | Zendy; Koren V. Kanadanian | Zendy; Jessica R. MacNeil | Zendy; Stacey W. Martin | Zendy; Lucy A. McNamara | Zendy; Kenneth Sicard | Zendy; Cynthia Vanner | Zendy; Jeni Vuong | Zendy; Xin Wang | Zendy; Utpala Bandy | Zendy; Manisha Patel | Zendy

Open Access

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College—Rhode Island, 2015–2016

Author(s) -

Heidi M. Soeters,

Melissa Whaley,

Nicole AlexanderScott,

Koren V. Kanadanian,

Jessica R. MacNeil,

Stacey W. Martin,

Lucy A. McNamara,

Kenneth Sicard,

Cynthia Vanner,

Jeni Vuong,

Xin Wang,

Utpala Bandy,

Manisha Patel

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix091

Subject(s) - carriage , medicine , neisseria meningitidis , outbreak , meningococcal vaccine , meningococcal disease , vaccination , virology , microbiology and biotechnology , immunology , immunization , biology , antibody , bacteria , genetics , pathology

Serogroup B meningococcal disease caused 7 US university outbreaks during 2013-2016. Neisseria meningitidis can be transmitted via asymptomatic nasopharyngeal carriage. MenB-FHbp (factor H binding protein), a serogroup B meningococcal (MenB) vaccine, was used to control a college outbreak. We investigated MenB-FHbp impact on meningococcal carriage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research